Fig. 1From: Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patientsSignificant positive correlation between baseline FIB4 score with posttreatment I-FABP level in HCV/HIV co-infected group (r = 0.283, P-value = 0.047)Back to article page